Robert Dreibelbis to Cost-Benefit Analysis
This is a "connection" page, showing publications Robert Dreibelbis has written about Cost-Benefit Analysis.
Connection Strength
0.042
-
Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis. 2009 Nov 01; 200 Suppl 1:S16-27.
Score: 0.021
-
Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries. J Infect Dis. 2009 Nov 01; 200 Suppl 1:S28-38.
Score: 0.021